| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1621 | -0,05% | €221,90M | €43,62K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1363 | +0,00% | €221,80M | €6,37K | |
ERC Allspring Multi-Sector Income Fund | €7,7499 | -0,77% | €221,76M | €49,21K | |
GLO Clough Global Opportunities Fund | €5,2226 | +0,50% | €221,69M | €103,52K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1535 | -0,09% | €221,57M | €106,77 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,5068 | -0,01% | €221,10M | €14,05K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €10,9704 | -0,86% | €220,61M | €57,52K | |
| €3,5133 | +5,16% | €220,35M | €154,93K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,3347 | -7,19% | €220,15M | €2,44M | |
PNNT Pennant Investment Corp | €3,4616 | +3,34% | €219,84M | €631,37K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7832 | -0,10% | €219,58M | €180,83 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0554 | +0,29% | €219,50M | €63,34K | |
| €34,0436 | +3,71% | €219,49M | €8,05K | |
DSP Viant Technology Inc. Class A Common Stock | €10,9532 | +5,12% | €219,30M | €181,48K | |
| €25,1140 | +2,12% | €219,19M | €65,42K | |
